Vivani Medical
VANI
43 hedge funds and large institutions have $14.6M invested in Vivani Medical in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 9 closing their positions.
15,033% more call options, than puts
Call options by funds: $908K | Put options by funds: $6K
66% more capital invested
Capital invested by funds: $8.8M → $14.6M (+$5.83M)
11% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 9
0% more funds holding
Funds holding: 43 → 43 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.56% → 0.56% (+0%)
25% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 12
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$550K |
| 2 |
JP Morgan Chase
New York
|
+$234K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$117K |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$104K |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$96.9K |
Top Sellers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$618K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$145K |
| 3 |
Millennium Management
New York
|
-$140K |
| 4 |
Squarepoint
New York
|
-$50K |
| 5 |
FTI
Fiduciary Trust International
Lincoln,
Massachusetts
|
-$31K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$631 | +19 | +950% |
|
VANI Hedge Fund Activity: Q4 2017 in Review
43 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q4 2017, worth a combined $14.6M — up 66% from $8.8M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new VANI positions and 9 closed out — a net gain of 1 holder — while 9 added to existing stakes and 12 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $550K. The largest seller was BNP Paribas Financial Markets, exiting entirely with an estimated $618K sold.
- 43 institutional investors held Vivani Medical (VANI) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $14.6M of Vivani Medical stock for Q4 2017, up 66% quarter-over-quarter.
- 10 funds opened new Vivani Medical positions in Q4 2017 and 9 closed out, a net change of +1 holder.
- The largest Vivani Medical buyer in Q4 2017 was Virtu Financial, an estimated $550K added.
- The largest Vivani Medical seller in Q4 2017 was BNP Paribas Financial Markets, an estimated $618K sold.
Based on aggregated 13F filings for Q4 2017.